AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DICHLORHYDRATE DE TRIMETAZIDINE

10 registrations across 2 African markets— 8 active

Markets with DICHLORHYDRATE DE TRIMETAZIDINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
VASTAREL 35MG COMPRIME PELLICULE A LIBERATION MODIFIEE BOITE DE 60🇨🇮Côte d'IvoireLES LABORATOIRES SERVIERactiveNov 2026
TRIMAREL 35MG COMPRIME PELLICULE A LIBERATION MODIFIEE BOITE DE 60🇨🇮Côte d'IvoireLABORATOIRE BOTTU S.AexpiredJan 2026
VASTAREL 80MG GELULE A LIBERATION PROLONGEE BOITE DE 30🇨🇮Côte d'IvoireLES LABORATOIRES SERVIERexpiredApr 2024
TRIMAREL
comprimé / 20 mg
🇸🇳SenegalBOTTU SAactive
VASTAREL
suspension buvable / 20 mg
🇸🇳SenegalSERVIER MAROCactive
VASTAREL LM
comprimé / 35 mg
🇸🇳SenegalSERVIER MAROCactive
VASCOR
comprimé / 20 mg
🇸🇳SenegalCOOPER PHARMAactive
VASCOR
solution buvable en gouttes / 20 mg/ml
🇸🇳SenegalCOOPER PHARMAactive
TRIMAREL
suspension buvable / 20 mg/ml
🇸🇳SenegalBOTTU SAactive
VASTAREL
gélule / 80 mg
🇸🇳SenegalSERVIER MAROCactive

DICHLORHYDRATE DE TRIMETAZIDINE in Africa — Regulatory Overview

DICHLORHYDRATE DE TRIMETAZIDINE is registered across 2 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Côte d'Ivoire. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 8 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.